In-Silico Screening of Potential Anti-Androgenic and Anti-Estrogenic Phytocompounds from Saraca Asoca for Polycystic Ovary Syndrome Treatment
January 2024
in “
Journal of Applied Pharmaceutical Science
”
Studysummary This study identified procyanidin B2 and leucopelargonidin from Saraca asoca as potential inhibitors in PCOS by showing high binding energy scores against key enzymes involved in estrogen and testosterone biosynthesis.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on japsonline.com →